OBJECTIVE: Evaluations of plasma leptin and ghrelin levels and their relations with circulating levels of proinflammatory mediators, stress hormones, and biochemical markers of hepatorenal injury during experimental endotoxemia in dogs. SETTING: Uludag University. DESIGN: Placebo-controlled animal study. ANIMALS: Adult mongrel dogs (n = 16). INTERVENTIONS: Intravenous injection of endotoxin (1 mg/kg) and blood sample withdrawal before and at 0.5-48 hrs posttreatment. MEASUREMENTS AND MAIN RESULTS: Mean baseline plasma leptin and ghrelin levels were 2.4 +/- 0.1 ng/mL and 867 +/- 58 pg/mL, respectively. Plasma leptin and ghrelin increased significantly by 16% (p < .05) and 72% (p < .001) at 0.5 hr, and they remained elevated by 33-41% (p < .001) and 59-74% (p < .001) at 48 hrs after administration of endotoxin, respectively. There was positive correlation (r = .844; p < .001) between plasma leptin and ghrelin levels in endotoxin-treated dogs. Endotoxemia was associated with several-fold elevations in circulating levels of stress hormones, proinflammatory mediators, and hepatorenal injury markers. Plasma leptin and ghrelin levels in endotoxin-treated dogs were correlated with serum nitric oxide (r = .955 and r = .890; p < .001), procalcitonin (r = .825 and r = .716; p < .001), cortisol (r = .823 and r = .786; p < .001), and hepatorenal injury markers (r = .580 to .745 and r = .393 to .574; p < .05 to .01). CONCLUSIONS: Circulating leptin and ghrelin levels increase during endotoxemia, and these increases are associated with elevated levels of proinflammatory mediators, stress hormones, and serum biochemical markers for hepatorenal dysfunction.
OBJECTIVE: Evaluations of plasma leptin and ghrelin levels and their relations with circulating levels of proinflammatory mediators, stress hormones, and biochemical markers of hepatorenal injury during experimental endotoxemia in dogs. SETTING: Uludag University. DESIGN: Placebo-controlled animal study. ANIMALS: Adult mongrel dogs (n = 16). INTERVENTIONS: Intravenous injection of endotoxin (1 mg/kg) and blood sample withdrawal before and at 0.5-48 hrs posttreatment. MEASUREMENTS AND MAIN RESULTS: Mean baseline plasma leptin and ghrelin levels were 2.4 +/- 0.1 ng/mL and 867 +/- 58 pg/mL, respectively. Plasma leptin and ghrelin increased significantly by 16% (p < .05) and 72% (p < .001) at 0.5 hr, and they remained elevated by 33-41% (p < .001) and 59-74% (p < .001) at 48 hrs after administration of endotoxin, respectively. There was positive correlation (r = .844; p < .001) between plasma leptin and ghrelin levels in endotoxin-treated dogs. Endotoxemia was associated with several-fold elevations in circulating levels of stress hormones, proinflammatory mediators, and hepatorenal injury markers. Plasma leptin and ghrelin levels in endotoxin-treated dogs were correlated with serum nitric oxide (r = .955 and r = .890; p < .001), procalcitonin (r = .825 and r = .716; p < .001), cortisol (r = .823 and r = .786; p < .001), and hepatorenal injury markers (r = .580 to .745 and r = .393 to .574; p < .05 to .01). CONCLUSIONS: Circulating leptin and ghrelin levels increase during endotoxemia, and these increases are associated with elevated levels of proinflammatory mediators, stress hormones, and serum biochemical markers for hepatorenal dysfunction.
Authors: Flavia R Teles; Ricardo P Teles; Lynn Martin; Sigmund S Socransky; Anne D Haffajee Journal: J Periodontol Date: 2011-12-19 Impact factor: 6.993
Authors: Alexander Koch; Edouard Sanson; Anita Helm; Sebastian Voigt; Christian Trautwein; Frank Tacke Journal: Crit Care Date: 2010-05-25 Impact factor: 9.097
Authors: Daniel Siegl; Emily F Midura; Thorsten Annecke; Peter Conzen; Charles C Caldwell; Johannes Tschoep Journal: PLoS One Date: 2015-04-06 Impact factor: 3.240
Authors: F Bonelli; V Meucci; T J Divers; E Jose-Cunilleras; M Corazza; R Tognetti; G Guidi; L Intorre; M Sgorbini Journal: J Vet Intern Med Date: 2015-10-16 Impact factor: 3.333